RVTY
Ticker
Revvity Inc
Company
Diagnostics
Industry
Healthcare
Sector
Financial Ratio Analysis
+
2009
+
2010
+
2011
+
2012
+
2013
+
2014
+
2015
+
2016
+
2017
+
2018
+
2019
+
2020
+
2021
+
2022
+
2023
+
2024
+
2025
TTM
Revenue Growth YoY
β€”9.9%12.6%10.3%2.0%3.7%-5.9%0.5%6.7%23.1%3.8%31.2%34.0%-34.6%-16.9%0.2%β€”3.4%
Revenue Growth QoQ
β€”9.9%12.6%10.3%2.0%3.7%-5.9%0.5%6.7%23.1%3.8%31.2%34.0%-34.6%-16.9%0.2%β€”β€”
Gross Margin
45.1%44.5%44.2%45.5%45.2%44.9%48.7%47.9%47.6%48.3%48.4%55.8%56.3%60.1%56.0%55.8%β€”55.3%
EBITDA Margin
13.1%14.5%10.5%10.7%16.4%14.6%18.6%18.1%17.8%18.2%20.0%32.4%32.4%35.3%26.6%28.1%β€”27.4%
Operating Margin
7.9%9.2%4.7%4.7%10.6%9.4%13.6%13.4%13.1%11.7%12.6%25.9%26.3%22.4%10.9%12.6%β€”12.9%
Profit Margin
5.5%22.9%0.4%3.3%7.7%7.1%10.1%11.1%13.0%8.6%7.9%19.2%18.6%17.2%25.2%9.8%β€”8.4%
FCF / EBITDA
60.8%52.9%96.2%48.7%33.7%77.1%66.1%83.3%62.2%43.2%49.9%66.5%80.6%50.8%1.4%69.9%β€”64.5%